TB-008

N/A

Report date: 2026/03/06 20:02:51
NMEFirst In Class

Base Information

Drug NameTB-008
Drug Alias NameTB-008TB008
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionCyclin-dependent kinase 9 degraders
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTherabene Inc
China Registration ClassN/A

Develop Information

Active CompaniesTherabene Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A